Clinical Trial Update: An Epidemiological Study to Describe Symptom Control and Impact of Gastroesophageal Reflux Disease

View source ↗

Summary

A completed epidemiological study sponsored by AstraZeneca describes symptom control and the impact of gastroesophageal reflux disease. The update provides resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: GERD | Status: COMPLETED